Update on Atrial Shunt Therapy for Treatment of Heart Failure

This publication has 37 references indexed in Scilit:

• Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure
  Circulation: Heart Failure, 2016
• Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study
  The Lancet, 2016
• A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial
  The Lancet, 2016
• Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial
  Journal of Cardiac Failure, 2015
• Clinical outcome of transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel implant
  International Journal of Cardiology, 2015
• Transcatheter Treatment of Heart Failure with Preserved or Mildly Reduced Ejection Fraction Using a Novel Interatrial Implant to Lower Left Atrial Pressure
  European Journal of Heart Failure, 2014
• Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
  European Heart Journal, 2014
• Spironolactone for Heart Failure with Preserved Ejection Fraction
  New England Journal of Medicine, 2014
• Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
  New England Journal of Medicine, 2008
• Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
  The Lancet, 2003